CLINICAL_TRIALS ClinicalTrials.gov record update

To Assess the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Pneumococcal Conjugate Vaccine Compared to Prevenar™, Co-administered With DTPw-HBV/Hib & OPV or IPV Vaccines as a 3-dose Primary Immunization Course During the First 6 Months of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00344318
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:04.656356+00:00
Published At: 2018-12-07T00:00:00+00:00
Record Updated At: 2018-12-07
Results Posted At: 2018-12-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infections, Streptococcal"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-12-07"
protocolSection.identificationModule.nctId: "NCT00344318"
protocolSection.identificationModule.officialTitle: "To Assess the Safety, Reactogenicity and Immunogenicity of GSK Biologicals\u0027 Pneumococcal Conjugate Vaccine Compared to Prevenar\u2122, Co-administered With DTPw-HBV/Hib \u0026 OPV or IPV Vaccines as a 3-dose Primary Immunization Course During the First 6 Months of Age"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-12-07"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.